Hello and welcome to the details of J&J's Covid-19 vaccine shows strong activity against Delta variant and now with the details
WASHINGTON, July 2 ― Johnson & Johnson said late yesterday that its single-shot Covid-19 vaccine generated strong, persistent activity against the Delta and other highly prevalent variants.
Data showed that the durability of the immune response lasted through at least eight months, the US-based healthcare company said, adding that its vaccine was 85 per cent effective and could also help prevent hospitalisation and death.
“Current data for the eight months studied so far shows that the single-shot Johnson & Johnson Covid-19 vaccine generates a strong neutralising antibody response that does not wane; rather, we observe an improvement over time,” Mathai Mammen, head of research & development at J&J's drugs business, said in the statement.
The Covid-19 vaccine elicited neutralising antibody activity against the Delta variant, first identified in India, at an even higher level than what was observed for the Beta variant, which was first detected in South Africa, the company said.
J&J has submitted data as a preprint to the website bioRxiv ahead of peer review. ― Reuters
These were the details of the news J&J's Covid-19 vaccine shows strong activity against Delta variant for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.